干细胞
干细胞疗法
肌萎缩侧索硬化
神经科学
神经干细胞
医学
细胞疗法
间充质干细胞
胚胎干细胞
疾病
移植
脊髓损伤
多发性硬化
病理
生物
免疫学
脊髓
外科
生物化学
遗传学
基因
作者
Nidhi Puranik,Ananta Prasad Arukha,Shiv Kumar Yadav,Dhananjay Yadav,Jun‐O Jin
出处
期刊:Current stem cell research & therapy
[Bentham Science]
日期:2021-09-06
卷期号:17 (2): 113-125
被引量:10
标识
DOI:10.2174/1574888x16666210810103838
摘要
Several human neurological disorders, such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, spinal cord injury, multiple sclerosis, and brain stroke, are caused by the injury to neurons or glial cells. The recent years have witnessed the successful generation of neurons and glia cells driving efforts to develop stem-cell-based therapies for patients to combat a broad spectrum of human neurological diseases. The inadequacy of suitable cell types for cell replacement therapy in patients suffering from neurological disorders has hampered the development of this promising therapeutic approach. Attempts are thus being made to reconstruct viable neurons and glial cells from different stem cells, such as embryonic stem cells, mesenchymal stem cells, and neural stem cells. Dedicated research to cultivate stem cell-based brain transplantation therapies has been carried out. We aim at compiling the breakthroughs in the field of stem cell-based therapy for the treatment of neurodegenerative maladies, emphasizing the shortcomings faced, victories achieved, and the future prospects of the therapy in clinical settings.
科研通智能强力驱动
Strongly Powered by AbleSci AI